A carregar...
Development of a Metabolic Biosignature for Detection of Early Lyme Disease
Background. Early Lyme disease patients often present to the clinic prior to developing a detectable antibody response to Borrelia burgdorferi, the etiologic agent. Thus, existing 2-tier serology-based assays yield low sensitivities (29%–40%) for early infection. The lack of an accurate laboratory t...
Na minha lista:
| Publicado no: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4810808/ https://ncbi.nlm.nih.gov/pubmed/25761869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ185 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|